Skip to main content

Table 5 Severity categories of depression and anxiety in total cohort and subgroups

From: The hidden crisis: COVID-19 and impact on mental health of medical students in Pakistan

  

Gender

 

Phase of study

 

Past H/O psychiatric illness

 
 

N (%)

 

No. (%)

 

No. (%)

Severity category

Total No. (%)

1100

Men

(N = 344)

Women

(N = 756)

P value

Preclinical

(N = 446)

Clinical

(N = 653)

 

Yes

(N = 299)

No

(N = 801)

P Value

PHQ-9, depression symptoms

 Normal

274 (24.9)

120 (34.9)

154 (20.4)

0.000**

93 (20.9)

181 (27.7)

0.021*

38 (12.7)

236 (29.5)

0.000**

 Mild

297 (27.0)

89 (25.9)

208 (27.5)

123 (27.6)

174 (26.6)

 

61 (20.4)

236 (29.5)

 Moderate

209 (19.1)

58 (16.9)

152 (20.1)

82 (18.4)

127 (19.4)

 

65 (21.7)

145 (18.1)

 Severe

319 (29.0)

77 (22.4)

242 (32.0)

148 (33.2)

171 (26.2)

 

135 (45.2)

184 (23.0)

GAD-7, anxiety symptoms

 Normal

367 (33.4)

171 (49.7)

196 (25.9)

0.000**

141 (31.6)

226 (34.6)

0.385

35 (11.7)

232 (41.4)

0.000**

 Mild

288 (26.3)

61 (17.7)

228 (32.2)

112 (25.1)

176 (27.0)

 

76 (25.4)

213 (26.6)

 Moderate

222 (20.2)

52 (15.1)

170 (22.5)

93 (20.9)

129 (19.8)

 

82 (27.4)

140 (17.5)

 Severe

222 (20.2)

60 (17.4)

162 (21.4)

100 (22.4)

122 (18.7)

 

106 (35.5)

116 (14.5)

  1. Abbreviations: PHQ-9 The 9-item Patient Health Questionnaire, GAD-7 7-item Generalized Anxiety Disorder
  2. *P value statistically significant <.05
  3. **P value < 0.001